432 related articles for article (PubMed ID: 12876066)
1. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
Arun KH; Kaul CL; Ramarao P
Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
[TBL] [Abstract][Full Text] [Related]
4. Regulation of inositol 1,4,5-trisphosphate receptors by transforming growth factor-beta: implications for vascular dysfunction in diabetes.
McGowan TA; Sharma K
Kidney Int Suppl; 2000 Sep; 77():S99-103. PubMed ID: 10997698
[TBL] [Abstract][Full Text] [Related]
5. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
[TBL] [Abstract][Full Text] [Related]
7. Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice.
Sharma K; Wang L; Zhu Y; DeGuzman A; Cao GY; Lynn RB; Joseph SK
Am J Physiol; 1999 Jan; 276(1):F54-61. PubMed ID: 9887080
[TBL] [Abstract][Full Text] [Related]
8. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
10. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
[TBL] [Abstract][Full Text] [Related]
12. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
[TBL] [Abstract][Full Text] [Related]
14. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells.
Park SH; Han HJ
Am J Physiol Renal Physiol; 2002 Feb; 282(2):F228-37. PubMed ID: 11788436
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
17. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
[TBL] [Abstract][Full Text] [Related]
18. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1.
McKay S; de Jongste JC; Saxena PR; Sharma HS
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):823-33. PubMed ID: 9618387
[TBL] [Abstract][Full Text] [Related]
20. Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression.
Suzuki H; Yamamoto T; Ikegaya N; Hishida A
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F267-77. PubMed ID: 14559715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
